Do Serum Galectin-9 Levels in Women with Gestational Diabetes and Healthy Ones Differ before or after Delivery? A Pilot Study
-
Published:2023-04-20
Issue:4
Volume:13
Page:697
-
ISSN:2218-273X
-
Container-title:Biomolecules
-
language:en
-
Short-container-title:Biomolecules
Author:
Pełech Aleksandra1ORCID, Ruszała Monika1, Niebrzydowska-Tatus Magdalena1ORCID, Bień Katarzyna1, Kimber-Trojnar Żaneta1ORCID, Czuba Monika2, Świstowska Małgorzata2ORCID, Leszczyńska-Gorzelak Bożena1
Affiliation:
1. Department of Obstetrics and Perinatology, Medical University of Lublin, 20-090 Lublin, Poland 2. Department of Clinical Genetics, Medical University of Lublin, 20-080 Lublin, Poland
Abstract
Gestational diabetes mellitus (GDM) is a common metabolic disease that occurs during pregnancy, with the placenta playing an important role in its pathophysiology. Currently, the role of galectin-9 in the development of GDM is unknown. The aim of this study was to compare galectin-9 concentrations in healthy pregnant women and those with GDM. Galectin-9 levels were assessed in serum samples taken both just before and after delivery, as well as in urine samples collected in the postpartum period. Maternal body composition and hydration status were evaluated using the bioelectrical impedance analysis (BIA) method. There were no statistically significant differences in the concentration of galectin-9 in women with GDM compared to healthy pregnant women in their serum samples taken just before delivery, nor in their serum and urine samples collected in the early postpartum period. However, serum galectin-9 concentrations taken before delivery were positively correlated with BMI and parameters related to the amount of adipose tissue assessed in the early postpartum period. Additionally, there was a correlation between serum galectin-9 concentrations taken before and after delivery. Galectin-9 is unlikely to become a diagnostic marker for GDM. However, this subject requires further clinical research in larger groups.
Funder
Medical University of Lublin
Subject
Molecular Biology,Biochemistry
Reference41 articles.
1. Hepp, P., Unverdorben, L., Hutter, S., Kuhn, C., Ditsch, N., Groß, E., Mahner, S., Jeschke, U., Knabl, J., and Heidegger, H.H. (2020). Placental Galectin-2 Expression in Gestational Diabetes: A Systematic, Histological Analysis. Int. J. Mol. Sci., 21. 2. Modzelewski, R., Stefanowicz-Rutkowska, M.M., Matuszewski, W., and Bandurska-Stankiewicz, E.M. (2022). Gestational Diabetes Mellitus—Recent Literature Review. J. Clin. Med., 11. 3. Placental pathologic changes in gestational diabetes mellitus;Jarmuzek;Neuroendocrinol. Lett.,2015 4. Association of circulating galectin-3 with gestational diabetes mellitus, progesterone, and insulin resistance;Zhang;J. Diabetes,2021 5. Getting too sweet: Galectin-1 dysregulation in gestational diabetes mellitus;Blois;Mol. Hum. Reprod.,2014
|
|